News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Mesothelin Finding Could Lead to Early Detection of Mesothelioma
- New York Attorney Calls for International Ban on Mesothelioma-Causing Asbestos
- Protein Can be Reliable for Diagnosing Malignant Mesothelioma
- Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
- Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
- Options for Funding Mesothelioma Research
- Golf Outing to Raise Funds for Mesothelioma Research
- 3 Year Mesothelioma Survivor Stays Busy Raising Awareness of the Disease
- MesotheliomaHelp Website Offers Mesothelioma-Related FAQs
- CDMRP System Offers Funding Opportunity to Help Military Mesothelioma Sufferers
Thursday, November 26, 2009
As part of the Lung Cancer Clinical Trials Call to Action Campaign , Lung Cancer Alliance, National Lung Cancer Partnership, and other advocacy groups have partnered with EmergingMed to offer a personalized service for lung cancer patients “to take charge of their diagnosis and learn about clinical trials, which are an important part of treatment innovation.”
The initiative matches lung cancer patients with currently recruiting clinical trials based on the patient’s diagnosis. After building a profile covering areas such as activity level, level of cancer metastasis, type of cancer such as mesothelioma, treatment regimen, and other conditions, the patient is presented with a list of clinical trials for consideration.
The campaign partners recommend that patients search for clinical trial options prior to the start of their treatment and again when faced with new treatment decisions.
EmergingMed was founded in 2000 with a goal “to increase clinical trial awareness and access through one-on-one, personalized services provided through collaborations with a growing partner network.”
Labels: ClinicalTrial
posted by Nancy Meredith at 2:00 PM
